Gene Salkind

Gene Z.
Salkind is currently the Chairman at Mobiquity Technologies, Inc., the Director at CURE Pharmaceutical Corp., the Independent Director at Upexi, Inc., the Independent Director at Avenir Wellness Solutions, Inc., the Independent Director at Coeptis Therapeutics Holdings, Inc., the Chief-Neurosurgery at Holy Redeemer Health System, and the President at Bruno & Salkind Mds.
He has also served as a Trustee at Calico Capital Management LLC, a Trustee-Emeritus at Temple University School of Medicine, and a Professor at Lewis Katz School of Medicine.
In his former positions, he was a Director at Grove Holdings, Inc., a Director at DermTech Operations, Inc., a Director at DermTech, Inc., a Professor at the University of Pennsylvania, a Professor at Allegheny Health, Education & Research Foundation, the Chief-Neurosurgery at Jeanes Hospital, and the Chief-Neurosurgery at Albert Einstein Medical Center.
Dr. Salkind obtained his undergraduate degree from the University of Pennsylvania in 1974, his doctorate from Temple University School of Medicine in 1997, and another doctorate from Lewis Katz School of Medicine in 1979.